Who should not use Mounjaro?

Mounjaro should not be used for weight loss by people who have or have ever had medullary thyroid cancer, a rare condition called Multiple Endocrine Neoplasia Syndrome Type 2 (MEN-2), or those who are allergic to tirzepatide or any of its ingredients. It is also not suitable for anyone who is pregnant, breastfeeding, or has a history of pancreatitis. People with type 1 diabetes should avoid Mounjaro, and anyone taking certain medications (such as insulin, sulfonylureas) should consult their doctor due to possible interactions.

  • Personal or family history of medullary thyroid cancer
  • Diagnosis of Multiple Endocrine Neoplasia Syndrome Type 2 (MEN-2)
  • Allergy to tirzepatide or any Mounjaro ingredients
  • Pregnant or breastfeeding women
  • History of pancreatitis
  • People with type 1 diabetes
  • Those on medicines that may interact with Mounjaro (e.g., insulin, sulfonylureas)

This text has been fact checked for accuracy by Sorin Romaniuc, Pharmacist at medino.

Compare doses and prices: View Weight Loss range